Catalyst Pharmaceuticals Ownership | Who Owns Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals Ownership Summary
Catalyst Pharmaceuticals is owned by 84.75% institutional investors, 5.57% insiders, and 9.68% retail investors. Blackrock is the largest institutional shareholder, holding 16.01% of CPRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.75% of its assets in Catalyst Pharmaceuticals shares.
CPRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Catalyst Pharmaceuticals | 84.75% | 5.57% | 9.68% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 18.69M | 16.01% | $289.58M |
| Blackrock funding, inc. /de | 18.77M | 15.35% | $464.86M |
| Vanguard group | 8.43M | 6.88% | $196.81M |
| State street | 6.86M | 5.61% | $169.93M |
| American century companies | 4.14M | 3.38% | $102.47M |
| Deerfield management company, l.p. (series c) | 3.94M | 3.22% | $97.64M |
| Dimensional fund advisors lp | 3.43M | 2.80% | $84.91M |
| Geode capital management | 2.97M | 2.43% | $73.61M |
| Morgan stanley | 2.69M | 2.20% | $66.54M |
| Renaissance | 2.35M | 1.92% | $58.12M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Gables capital management | 424.58K | 4.45% | $10.51M |
| Tanaka capital management | 114.42K | 4.06% | $2.25M |
| Jw asset management | 388.39K | 3.95% | $9.62M |
| Knott david m jr | 120.00K | 1.77% | $2.97M |
| Globeflex capital l p | 450.58K | 1.69% | $11.16M |
| Advisors preferred | 381.18K | 1.39% | $9.44M |
| Qsv equity investors | 36.01K | 1.24% | $840.47K |
| Mesirow institutional investment management | 742.29K | 1.19% | $15.49M |
| Deerfield management company, l.p. (series c) | 3.94M | 1.15% | $97.64M |
| Bridge city capital | 155.69K | 1.07% | $3.85M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| American century companies | 4.14M | 0.05% | 1.11M |
| Blackrock | 18.69M | 0.01% | 962.28K |
| Vanguard fiduciary trust | 802.63K | 0.01% | 802.63K |
| Susquehanna group, llp | 852.82K | 0.00% | 688.61K |
| Glenmede investment management, lp | 680.22K | 0.06% | 603.08K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fundsmith llp | 844.89K | 0.16% | -2.52M |
| Deerfield management company, l.p. (series c) | 3.94M | 1.15% | -967.56K |
| Macquarie group | - | - | -761.74K |
| Arrowstreet capital, limited partnership | 955.32K | 0.01% | -661.89K |
| Invesco | 752.84K | 0.00% | -540.64K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 802.63K | 0.01% | 802.63K | $19.87M |
| Clark capital management group | 568.68K | 0.09% | 568.68K | $14.08M |
| Imc-chicago | 563.67K | 0.01% | 563.67K | $13.96B |
| William blair investment management | 479.04K | 0.04% | 479.04K | $11.86M |
| Point72 asset management | 425.87K | 0.01% | 425.87K | $10.54M |
Sold Out
| Holder | Change |
|---|---|
| Global financial private client | -1.00 |
| Grey fox wealth advisors | -1.00 |
| Concord wealth partners | -1.00 |
| Turning point benefit group | -2.00 |
| Optima capital | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 384 | 1.59% | 103,640,760 | -0.34% | 84 | 1.18% | 200 | 5.26% | 119 | -6.30% |
| Dec 31, 2025 | 317 | -13.39% | 84,692,615 | -18.03% | 69 | 0.97% | 157 | -11.30% | 105 | -21.64% |
| Sep 30, 2025 | 351 | -3.57% | 103,180,919 | 1.77% | 84 | 1.23% | 169 | -19.52% | 129 | 5.74% |
| Jun 30, 2025 | 354 | -3.54% | 101,094,756 | 3.01% | 82 | 1.27% | 204 | 3.55% | 118 | -2.48% |
| Mar 31, 2025 | 361 | 6.80% | 97,419,101 | -0.16% | 80 | 1.19% | 193 | -4.46% | 119 | 33.71% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 7.04M | 5.75% | 1.54K |
| Avantis US Small Cap Value ETF | 3.81M | 3.11% | - |
| Vanguard Total Stock Mkt Idx Inv | 3.73M | 3.05% | 12.91K |
| Vanguard US Total Market Shares ETF | 3.55M | 2.91% | 3.78K |
| Smithson Investment Trust Ord | 3.36M | 2.75% | - |
| iShares Russell 2000 ETF | 2.73M | 2.22% | 22.98K |
| State Street® SPDR® S&P® Biotech ETF | 2.53M | 2.07% | -25.00K |
| First Trust NYSE Arca Biotech ETF | 1.89M | 1.59% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.30M | 1.07% | 15.37K |
| SPDR® S&P Biotech ETF | 1.17M | 0.95% | 2.60K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Harper Molly | - | Sell | $155.56K |
| Dec 12, 2025 | Harper Molly | - | Sell | $106.16K |
| Dec 12, 2025 | Harper Molly | - | Sell | $360.20K |
| Nov 26, 2025 | Del Carmen Jeffrey | Chief Commercial Officer | Sell | $256.24K |
| Nov 12, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Buy | $908.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 7 |
CPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools